Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis
Open Access
- 1 December 2001
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 104 (4) , 423-430
- https://doi.org/10.1046/j.1365-2567.2001.01316.x
Abstract
The open environment of the eye is continuously subject to an influx of foreign agents that can activate complement. Decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 are regulators that protect self-cells from autologous complement activation on their surfaces. They are expressed in the eye at unusually high levels but their physiological importance in this site is unstudied. In the rat, a structural analogue termed 5I2 antigen (5I2 Ag) has actions overlapping DAF and MCP. In this investigation, we injected F(ab′)2 fragments of 5I2 mAb into the conjunctiva and aqueous humor, in the latter case with and without concomitant blockage of CD59. Massive neutrophilic infiltration of the stroma and iris resulted upon blocking 5I2 Ag activity. Frank necrosis of the iris occurred upon concomitant intraocular blockage of CD59. C3b was identified immunohistochemically, and minimal effects were seen in complement-depleted animals and in those treated with non-relevant antibody. The finding that blockage of 5I2 Ag function in periocular tissues and within the eye causes intense conjunctival inflammation and iritis demonstrates the importance of intrinsic complement regulators in protecting ocular tissues from spontaneous or bystander attack by autologous complement.Keywords
This publication has 47 references indexed in Scilit:
- Immunohistochemical Staining of Retrobulbar Adipose Tissue in Graves' OphthalmopathyClinical Immunology and Immunopathology, 1994
- Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal glandCurrent Eye Research, 1994
- The control of homologous lysisImmunology Today, 1991
- H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complementCellular Immunology, 1990
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complementInternational Immunology, 1989
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Activation of mouse complement by monoclonal mouse antibodiesEuropean Journal of Immunology, 1981
- Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.British Journal of Ophthalmology, 1976